MELANIE SISULAK: Open Payments
NPI 1679699847 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,590 in 73 payments from 30 companies in 2025. Trend: 2023 $1,003 · 2024 $1,428 · 2025 $1,590
Food & beverage: $1,590
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $288 |
| Novartis Pharmaceuticals Corporation | 8 | $190 |
| Genentech, Inc. | 1 | $102 |
| Merck Sharp & Dohme LLC | 4 | $100 |
| E.R. Squibb & Sons, L.L.C. | 5 | $92 |
| BeOne Medicines USA, Inc. | 5 | $91 |
| Daiichi Sankyo Inc. | 4 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
| Exelixis Inc. | 2 | $48 |
| PFIZER INC. | 2 | $48 |
Products named: Columvi, KEYTRUDA, IMFINZI, OPDIVO, Enhertu, LYNPARZA, Fabhalta, BRUKINSA.
Industry payments across AL — which companies pay providers there.
